Skip to main content

Table 2 Demographics and clinical parameters of the study population

From: Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals

Parameters

Mild

Severe

Subjects enrolled

n = 30

n = 15

Median age (range)

39 (18–81)

48 (22–70)

Gender (M/F)

14/16

12/3

Fever, no. (%)

17 (57)

13 (87)

Chills, no. (%)

4 (13)

6 (40)

Cough, no. (%)

15 (50)

7 (47)

Sore throat, no. (%)

16 (53)

5 (33)

Runny nose, no. (%)

5 (17)

2 (13)

Taste loss, no. (%)

21 (70)

5 (33)

Smell loss, no. (%)

17 (57)

6 (40)

Muscle aches, no. (%)

24 (80)

9 (60)

Joint pain, no. (%)

18 (60)

5 (33)

Abdominal pain, no. (%)

2 (7)

1 (7)

Vomit, no. (%)

2 (7)

1 (7)

Diarrhea, no. (%)

4 (13)

6 (40)

Seizures, no. (%)

NIL

NIL

Hypertension, no. (%)

7 (23)

5 (33)

Diabetes, no. (%)

4 (13)

4 (27)

Asthma, no. (%)

1 (3)

1 (7)

Chronic kidney disease, no. (%)

NIL

NIL

Neuro, no. (%)

NIL

NIL

Heart, no. (%)

NIL

1 (7)

Rheumatic fever, no. (%)

NIL

NIL

Corticosteroids, no. (%)

NIL

3 (20)

Antiviral drug, no. (%)

NIL

4 (27)

Required hospitalization no. (%)

NIL

6 (40)

Required mechanical oxygen support no. (%)

NIL

NIL